-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
HOOKIPA Pharma Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2023.
- HOOKIPA Pharma Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$13.8M, a 27.4% increase year-over-year.
- HOOKIPA Pharma Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$43.4M, a 37.2% increase year-over-year.
- HOOKIPA Pharma Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$81.6M, a 25.7% decline from 2022.
- HOOKIPA Pharma Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$64.9M, a 14.2% increase from 2021.
- HOOKIPA Pharma Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$75.7M, a 71.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)